Read more stories about
Montana Biotech >>

MATR Sponsor:

MATR Supporters:

FDA approves the first biosimilar for the U.S. market

March 6, 2015View for printing

Biosimilars have been circulating in Europe since 2006. Now the U.S. can reap the benefits.

The U.S. Food and Drug Administration approved the first biosimilar for U.S. markets Friday, a decision that has big implications for drug spending.

by Laura Lorenzetti

Full Story: ... biosimilar/
No reader comments so far. Be the first to comment by clicking the button below.

Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

E-mail this page to a friend!